Search results
Katalin "Kati" Karikó (Hungarian: Karikó Katalin, pronounced [ˈkɒrikoː ˌkɒtɒlin]; born 17 January 1955) is a Hungarian-American biochemist who specializes in ribonucleic acid -mediated mechanisms, particularly in vitro-transcribed messenger RNA (mRNA) for protein replacement therapy.
Katalin Karikó, PhD, is a biochemist and researcher, best known for her contributions to mRNA technology and the COVID-19 vaccines. Karikó and Drew Weissman, MD, PhD , were jointly awarded the 2023 Nobel Prize in Medicine for their discoveries that enabled the modified mRNA technology used in Pfizer-BioNTech and Moderna’s vaccines to ...
Oct 2, 2023 · Biochemist Katalin Karikó and immunologist Drew Weissman won the Nobel Prize in Physiology or Medicine Monday for their foundational research showing that chemical modifications to the...
Facts. © Nobel Prize Outreach. Photo: Clément Morin. Katalin Karikó. The Nobel Prize in Physiology or Medicine 2023. Born: 17 January 1955, Szolnok, Hungary. Affiliation at the time of the award: Szeged University, Szeged, Hungary; University of Pennsylvania, Philadelphia, PA, USA.
Oct 1, 2021 · Description of Research Expertise. Dr. Katalin Karikó’s research has for decades focused on RNA-mediated mechanisms, with the ultimate goal of developing in vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered (with Penn Medicine colleague Drew Weissman) that nucleoside modifications ...
Katalin Karikó. BioNTech RNA Pharmaceuticals. Verified email at upenn.edu. mRNA-based therapy for protein replacement.
Interview with the 2023 Nobel Prize laureate in physiology or medicine Katalin Karikó on 6 December 2023 during the Nobel Week in Stockholm, Sweden. Read the interview. Katalin Karikó answers the following questions (the links below lead to clip on YouTube): 0:00 – What brought you to science?
